🎉 Exciting Updates from ENOTTA! 🎉 We are thrilled to announce two new appointments to our COST Action ENOTTA team: 1️⃣ Prof. Güldal İnal Gültekin joins us as the Co-Leader…
We are excited to announce the start of a new webinar series organized by Working Group 4 (WG-4) of ENOTTA. This series, titled “Pharmacoeconomics in Therapeutic Drug Monitoring of Antibodies…
COST Action ENOTTA, the European Network on Optimising Treatment with Therapeutic Antibodies in chronic inflammatory diseases (CA21147), is pleased to announce a unique opportunity for researchers and healthcare practitioners to…
We are excited to announce a leadership change in ENOTTA Working Group 3, “Assay Standardisation and Structured Overview on Participating Hospitals/Research Centres.” We extend our heartfelt gratitude to Prof. Silje…
As part of our dissemination activities, the , held on 20-21 June 2024 in Montpellier, France. The workshop, titled “ENOTTA – European Network on Optimising Treatment with Therapeutic Antibodies in…
WG3 just opened a short survey focusing on External Quality A (EQA) schemes for therapeutic drug monitoring used to guide clinical decision making. If you would like to participate, the…
The Extended Core Group meeting of COST Action CA 21147 ENOTTA was held in the picturesque island of Lemnos, Greece, from May 29th to 31st, 2024! ENOTTA, the “European Network…
We’re thrilled to announce the publication of our first paper titled: “Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe” This…
We are excited to announce our upcoming webinar series “Model-informed therapeutic drug monitoring of antibodies in chronic inflammatory diseases: Assembling a multidisciplinary puzzle“. The webinars will take place every second…
Based on results from the COST Action ENOTTA recent survey, ENOTTA members have penned an overview of laboratories active in the field of TDM of therapeutic antibodies and their approaches…